The impact of anogenital warts on health-related quality of life: a 6-month prospective study
Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
[引用][C] The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study
M DROLET, M BRISSON, E MAUNSELL… - Sexually transmitted …, 2011 - pascal-francis.inist.fr
The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective
Study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
Study CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …
[PDF][PDF] The impact of anogenital warts on health-related quality of life: a 6-month prospective study
M Drolet, M Brisson, E Maunsell… - Sexually transmitted …, 2011 - drive.google.com
Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
The impact of anogenital warts on health-related quality of life: a 6-month prospective study.
M Drolet, M Brisson, E Maunsell, EL Franco, F Coutlée… - 2011 - cabidigitallibrary.org
Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
The impact of anogenital warts on health-related quality of life: a 6-month prospective study.
M Drolet, M Brisson, E Maunsell, EL Franco… - Sexually Transmitted …, 2011 - europepmc.org
Background The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
The impact of anogenital warts on health-related quality of life: a 6-month prospective study
M Drolet, M Brisson, E Maunsell… - Sexually …, 2011 - pubmed.ncbi.nlm.nih.gov
Background The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
The Impact of Anogenital Warts on Health-Related Quality of Life: A 6-Month Prospective Study
M Drolet, M Brisson, E Maunsell, EL Franco… - Sexually Transmitted …, 2011 - JSTOR
Background: The burden of anogenital warts will be a determining factor when making
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …
decisions about the type of human papillomavirus (HPV) vaccine to be used (bivalent or …